Elaina Coleborn
Woolloongabba, QLD 4102, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Beyond the bench: teaching grant writing in immunotherapy training.
Journal: Trends in immunology
Published: April 05, 2026
Antitumor activity of violacein in osteosarcoma, neuroblastoma and triple-negative breast cancer spheroids.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: June 02, 2025
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 08, 2025
Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 06, 2024
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 27, 2024
Lipoprotein Association Fluorometry (LAF) as a Semi-Quantitative Characterization Tool to Assess Extracellular Vesicle-Lipoprotein Binding.
Journal: Journal of extracellular vesicles
Published: October 03, 2024
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
Journal: Clinical and translational medicine
Published: August 23, 2024
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth.
Journal: Cancer immunology, immunotherapy : CII
Published: January 31, 2024
Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammation.
Journal: Nature communications
Published: June 28, 2023
miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration.
Journal: Molecular therapy oncolytics
Published: April 28, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026